The global transplantation market was valued at USD 15.0 billion in 2022 and is projected to grow at a compound annual growth rate (CAGR) of 9.3% from 2023 to 2030. This growth is primarily driven by the increasing demand for innovative tissue and organ transplantation products, which are essential for the treatment of organ failure. Organ failure can result from a variety of factors, including severe trauma, blood loss, poisoning, drug abuse, leukemia, sepsis, and other acute illnesses. Among the most critical and sought-after organ transplants are those of the kidney, heart, liver, and lungs, with the demand for these transplants being particularly high worldwide.

The rising incidence of organ failure is largely attributable to unhealthy lifestyles, which are increasingly common across the globe. Factors such as poor dietary habits, alcohol consumption, lack of physical exercise, and substance abuse are major contributors to the decline in organ function and the need for transplants. As these issues continue to affect populations globally, the demand for organ and tissue transplants, as well as transplantation-related products, is expected to escalate over the coming years.

Factors Driving Market Growth

Several key factors are contributing to the expansion of the transplantation market:

1. Increased Demand for Transplants: As the incidence of organ failure rises, particularly in developed nations with high rates of chronic diseases, there is an increasing demand for organ transplants. The most commonly transplanted organs—kidneys, hearts, livers, and lungs—are in critical demand, driven by the growing prevalence of end-stage renal disease (ESRD), heart disease, and chronic liver diseases.

2. Advances in Transplantation Technologies: Technological innovations in transplant medicine, including improvements in organ preservation, immunosuppressive treatments, and surgical techniques, have significantly increased the success rates of transplant surgeries. This, in turn, has contributed to the growing popularity of organ transplantation as a treatment option.

3. Ageing Populations: In many parts of the world, particularly in developed countries, the population is ageing, leading to an increased incidence of age-related diseases such as cardiovascular diseases and kidney dysfunction, which necessitate organ transplants.

Gather more insights about the market drivers, restrains and growth of the Transplantation Market

Regional Insights

In 2022, North America led the global transplantation market with a dominant market share of 39.0%, and this trend is expected to continue throughout the forecast period. The region benefits from highly developed healthcare infrastructure, a strong regulatory framework, and the presence of major biotechnology and medical devices companies. Leading companies such as Arthrex, Inc., Zimmer Biomet, Medtronic, Novartis AG, and Stryker have significant operations in the region, contributing to the continued growth of the transplantation market. These companies play an important role in the development and commercialization of innovative transplantation solutions, further bolstering the market’s expansion.

The demand for organ transplants in North America has outpaced the availability of donated organs, particularly for critical organs like the kidney, liver, and heart. Over the last decade, the gap between the supply and demand for these organs has widened significantly. However, the region has witnessed substantial efforts from governments, non-governmental organizations (NGOs), and healthcare institutions to bridge this gap. These efforts include campaigns aimed at raising awareness about organ donation, improving donor registration processes, and implementing new policies that streamline the donation system.

For example, in 2020, the Human Resource & Services Administration (HRSA) launched the Hospital Organ Donor Campaign, which aimed to encourage hospitals and healthcare providers to increase the number of organ donations. This initiative resulted in a notable rise in organ donations in 2020 compared to the previous year. These continued efforts are expected to improve the availability of transplant organs and further stimulate the market growth in the region.

Asia Pacific Market Outlook

The Asia Pacific region is projected to experience the highest growth rate in the transplantation market during the forecast period, driven by several key factors:

1. Research on Stem Cells and In-Vitro Organ Development: The region has seen significant advancements in stem cell research aimed at developing in-vitro tissues and organs for transplantation. Countries like India, China, and others are investing heavily in biotechnological innovations, which is expected to drive demand for new transplant solutions.

2. Improving Healthcare Infrastructure: Countries in Asia, including India, Thailand, the Philippines, and Indonesia, are rapidly developing their healthcare systems, particularly in urban areas, where the demand for organ transplants is increasing. As these nations improve their medical infrastructure, the availability of transplant-related products and services is expected to expand, further stimulating market growth.

3. Rising Incidences of Chronic Diseases: The growing prevalence of chronic diseases, including heart disease, diabetes, and renal failure in the Asia Pacific region, is contributing to an increased need for organ transplants. The rising burden of these diseases, coupled with aging populations, is expected to fuel the demand for transplantation services.

Browse through Grand View Research's Medical Devices Industry Research Reports.

• The global probe reprocessing market size was valued at USD 844.87 million in 2024 and is anticipated to grow at a CAGR of 10.55 % from 2025 to 2030.

• The global surgical helmet market size was estimated at USD 79.50 million in 2024 and is projected to grow at a CAGR of 4.77% from 2025 to 2030. 

Key Companies and Market Share Insights

The transplantation market is highly fragmented, with numerous large, small, and medium-sized vendors operating across various regions. Some of the leading companies in the market include:

• Zimmer Biomet

• Medtronic

• Stryker Corporation

These industry leaders are actively engaged in product innovation, mergers and acquisitions, and regional expansion strategies to capture a larger market share. For example, strategic mergers and acquisitions enable companies to expand their product offerings and geographical reach, allowing them to better serve the growing demand for transplantation products globally.

An example of such innovation is the world's first robotic lung transplant, performed in April 2023 by a team of surgeons in Spain. The procedure used a robotic system known as Da Vinci, representing a significant leap forward in the field of organ transplantation. This novel robotic lung transplant procedure underscores the ongoing advancements in surgical technologies and highlights the increasing role of robotics and automation in transplantation surgeries.

Additionally, the market is witnessing a surge in the development of advanced technologies, such as 3D bioprinting, which holds the potential to revolutionize organ transplantation by enabling the regeneration of tissues and organs. In September 2020, CollPlant Biotechnologies, an Israeli biotech company, and United Therapeutics announced a collaboration to utilize 3D bioprinting for the development of human kidneys for transplantation. This partnership marks a significant milestone in the efforts to bioengineer functional organs, which could address the global organ shortage and improve transplant outcomes in the future.

Some of the prominent players in the global transplantation market include:

• Abbvie, Inc

• Arthrex, Inc.

• Zimmer Biomet

• Medtronic

• Novartis AG

• Strykers

• 21st Century Medicine

• BiolifeSolutions, Inc

• Teva Pharmaceuticals

• Veloxis Pharmaceutical

Order a free sample PDF of the Transplantation Market Intelligence Study, published by Grand View Research.